These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39239271)

  • 1. Development of a prognostic nomogram for esophageal squamous cell carcinoma patients received radiotherapy based on clinical risk factors.
    Li Y; Shao X; Dai LJ; Yu M; Cong MD; Sun JY; Pan S; Shi GF; Zhang AD; Liu H
    Front Oncol; 2024; 14():1429790. PubMed ID: 39239271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model.
    Kong J; Zhu S; Shi G; Liu Z; Zhang J; Ren J
    Front Oncol; 2021; 11():739933. PubMed ID: 34631575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
    Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
    Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.
    Xu Z; Ke H; Zheng B; Lin C; Zhang Y; Wang L; Lin Y; Ye Y; Cai L; You M; Chen J; Xu Y
    Cancer Control; 2023; 30():10732748231185025. PubMed ID: 37339928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.
    Lin Z; Chen YY; Liu CH; Panzuto F; Ramirez RA; Lang M; Kim H; Ding ZY
    J Gastrointest Oncol; 2023 Dec; 14(6):2309-2323. PubMed ID: 38196527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
    Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
    Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Novel Serum Exosomal MicroRNA Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.
    Liu T; Du LT; Wang YS; Gao SY; Li J; Li PL; Sun ZW; Binang H; Wang CX
    Front Oncol; 2020; 10():573501. PubMed ID: 33123480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Hypopharyngeal Squamous Cell Carcinomas: A Population-Based Study.
    Wang J; Liu X; Tang J; Zhang Q; Zhao Y
    Front Public Health; 2021; 9():815631. PubMed ID: 35096758
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis.
    Yu J; Hu W; Yao N; Sun M; Li X; Wang L; Yang Y; Li B
    Transl Oncol; 2021 Aug; 14(8):101127. PubMed ID: 34020370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics-clinical nomogram for preoperative lymph node metastasis prediction in esophageal carcinoma.
    Geng X; Zhang Y; Li Y; Cai Y; Liu J; Geng T; Meng X; Hao F
    Br J Radiol; 2024 Feb; 97(1155):652-659. PubMed ID: 38268475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT radiomics in the identification of preoperative understaging in patients with clinical stage T1-2N0 esophageal squamous cell carcinoma.
    Zhao B; Yan S; Jia ZY; Zhu HT; Shi YJ; Li XT; Qu JR; Sun YS
    Quant Imaging Med Surg; 2023 Dec; 13(12):7996-8008. PubMed ID: 38106287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
    Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection.
    Leng C; Cui Y; Chen J; Wang K; Yang H; Wen J; Fu J; Liu Q
    Front Oncol; 2022; 12():925685. PubMed ID: 35875105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival.
    Tian S; Ma R; Liu Y; Chen F; Huang X; Yang Q; Nian W; Fan Z
    Transl Cancer Res; 2024 Jun; 13(6):2971-2984. PubMed ID: 38988936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis.
    Wang W; Liu X; Dang J; Li G
    Front Oncol; 2023; 13():1132423. PubMed ID: 37035207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomogram and risk factors for predicting survival in patients with pT2N0M0 esophageal squamous carcinoma.
    Kang M; Wang Y; Yang M; Wang X; Zhu L; Zhang M
    Sci Rep; 2023 Mar; 13(1):4931. PubMed ID: 36967413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
    Han W; Weng K; Zhang P; Hong Z
    Front Surg; 2022; 9():1091601. PubMed ID: 36684142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computed tomography-based nomogram for neoadjuvant chemotherapy plus immunotherapy response prediction in patients with advanced esophageal squamous cell carcinoma.
    Guo WW; Zhou C; Gao D; Xu M; Gui Y; Zhou HY; Chen TW; Zhang XM
    Front Oncol; 2024; 14():1358947. PubMed ID: 38903718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a nomogram model to predict the overall survival rate of esophageal cancer patients receiving neoadjuvant chemotherapy: A population-based study.
    Yang Y; He C
    Front Surg; 2022; 9():1066092. PubMed ID: 36743892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.